Clinical Trial: The efficacy and safety of cryoablation combined with hepatic arterial infusion of iparomlimab and tuvonralimab (QL1706), intravenous dacarbazine, and oral lenvatinib in patients with liver metastases (China)

China, Oct. 1 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'The efficacy and safety of cryoablation combined with hepatic arterial infusion of iparomlimab and tuvonralimab (QL1706), intravenous dacarbazine, and oral lenvatinib in patients with liver metastases'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133704

Registration Time: 2026/09/30

Type: Interventional study

Primary Sponsor: Sun Yat-sen University Cancer Center

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=342682

Published by HT Digital Content Services with permission from Health Daily Digest....